Section 124.552. Information reporting.  


Latest version.
  •   1.  Each licensed pharmacy that dispenses controlled substances identified pursuant to section 124.554, subsection 1, paragraph “g”, to patients in the state, and each licensed pharmacy located in the state that dispenses such controlled substances identified pursuant to section 124.554, subsection 1, paragraph “g”, to patients inside or outside the state, unless specifically excepted in this section or by rule, shall submit the following prescription information to the program:

      a.  Pharmacy identification.

      b.  Patient identification.

      c.  Prescribing practitioner identification.

      d.  The date the prescription was issued by the prescribing practitioner.

      e.  The date the prescription was dispensed.

      f.  An indication of whether the prescription dispensed is new or a refill.

      g.  Identification of the drug dispensed.

      h.  Quantity of the drug dispensed.

      i.  The number of days’ supply of the drug dispensed.

      j.  Serial or prescription number assigned by the pharmacy.

      k.  Type of payment for the prescription.

      l.  Other information identified by the board and advisory council by rule.

      2.  Information shall be submitted electronically in a secure format specified by the board unless the board has granted a waiver and approved an alternate secure format.

      3.  Information shall be timely transmitted as designated by the board and advisory council by rule, unless the board grants an extension. The board may grant an extension if either of the following occurs:

      a.  The pharmacy suffers a mechanical or electronic failure, or cannot meet the deadline established by the board for other reasons beyond the pharmacy’s control.

      b.  The board is unable to receive electronic submissions.

      4.  This section shall not apply to a prescribing practitioner furnishing, dispensing, supplying, or administering drugs to the prescribing practitioner’s patient, or to dispensing by a licensed pharmacy for the purposes of inpatient hospital care, inpatient hospice care, or long-term residential facility patient care.

    2006 Acts, ch 1147, §3, 11

    ;

    2007 Acts, ch 126, §25, 26